Drug and assay co-development PowerPoint Template

Editable drug and assay co-development worksheet with a fictional worked example and a fill-in slide. Preview both pages; download the 2-slide PPTX for 1 credit.

View in library · PPTX · 1 credit

When to use this template

Drug-development and assay-development tracks have separate stage identities and planned evidence handovers; intended use, analytical validation and clinical validation are distinguished rather than collapsed into a generic launch date.

Drug and assay co-development — fictional example — Slide 1: fictional worked example

What you can edit

Edit the text, table cells and any native chart data in PowerPoint. The second slide keeps the structure and provides replacement fields. Chart templates use zero seed values on the fill-in slide; replace these together with the associated definitions and tables.

Drug and assay co-development — fill-in template — Slide 2: fill-in template

Use the evidence correctly

Original native lanes/blocks/connectors, no histology photos, source logos or prescribed regulatory sequence. Fictional handovers are planning assumptions, not claims that stage alignment or assay approval follows automatically. Analytical validation is not clinical validation or current clinical availability.

Define your population, reporting period, measures and evidence sources.
Duplicate the fill-in slide and replace every bracketed field and chart value.
Check units, denominators, labels and conclusions against your source before presenting.

View in library · PPTX · 1 credit

All example content is fictional. Original Slideration template; no company endorsement. Use in your own presentations and client work under our slide licence. Redistribution or resale of template files is not permitted.